Pencoyd’s team brings together expertise from a variety of backgrounds, with a strong emphasis on investment banking, royalty debt, securitization, pharmaceutical operations and IP. Our executives have worked for some of the world’s leading investment banks, listed debt providers and biotech companies.

Our experience and networks allow us to find, engage and transact opportunities that lie out of the mainstream health care investment focus, but represent exceptional potential for outsize returns if we structure and execute the transition of a company effectively

We are actively looking for new opportunities where the value of the assets held by a company are not fully recognized and we can be the catalyst to help unlock that potential.